# FDA Inspection 1291782 - Renata Stawerska, MD, PhD - October 24, 2025

Source: https://www.keypedia.com/records/fda_inspections/renata-stawerska-md-phd/abb622dd-229c-42a4-8ea4-aaae5bbd1cde
Source feed: FDA_Inspections

> FDA Inspection 1291782 for Renata Stawerska, MD, PhD on October 24, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1291782
- Company Name: Renata Stawerska, MD, PhD
- Inspection Date: 2025-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1291782 - 2025-10-24](https://www.keypedia.com/records/fda_inspections/renata-stawerska-md-phd/1ca46f54-1ab2-4d69-a6be-2099f2a11eb3)

Company: https://www.keypedia.com/companies/renata-stawerska-md-phd/d9da4010-18df-4bcf-afe2-45e61faa496b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c